Abstract: An eFuse cell is provided. The eFuse cell may include a first PMOS transistor and a first NMOS transistor configured to receive a programmed state selection (BLOWB) signal, a second PMOS transistor and a second NMOS transistor configured to receive a write word line bar (WWLB) for a program operation, a first read NMOS transistor and a second read NMOS transistor configured to receive a read word line (RWL) for a read operation, a program transistor configured to control a program current to flow for a fusing operation, and an eFuse connected between the first read NMOS transistor and the second read NMOS transistor.

Abstract: A semiconductor device includes a first word line configured to perform a writing operation or a programing operation, a second word line configured to perform a read operation, a first switching device including a first gate electrode and a first node, a second switching device comprising a second gate electrode and a second node, an electrical fuse (e-fuse) disposed between the first node and the second node, and a diode coupled to the first node and the first word line, wherein the first gate electrode and the second gate electrode are coupled to the second word line.

Abstract: Proposed are a laminating apparatus and a method for manufacturing a vehicle seat. The laminating apparatus includes a first lamination part (100); a second lamination part (200); and a drying part (300), wherein the first lamination part (100) includes: a polyurethane foam feeding roll (110); a first bonding part (120); a fabric feeding roll (130) mounted on a side of the first lamination part (100); and a first pressing part (140), the second lamination part (200) includes: a second application part (210); a backing cloth feeding roll (220); and a second pressing part (230), and the drying part (300) includes: a feed part (310); and a chamber part (320).

Abstract: A terminal assembly of a driving motor includes: a support ring surrounding a stator core to which bobbins are coupled, the bobbins being configured to allow stator coils to be wound thereon; a first sub-assembly disposed on the support ring to surround the bobbins; and a second sub-assembly connected to the first sub-assembly, the second sub-assembly including fixing portions inserted into coupling recesses formed in the bobbins. Three-phase bus bars connected to three-phase lead wires of the stator coils are inserted into the first sub-assembly and an N-phase bus bar connected to N-phase lead wires of the stator coils is inserted into the second sub-assembly.

Abstract: Provided is a method for treating or preventing cancer, containing, as an active ingredient, a compound having a specific chemical structure and an activity of inhibiting the formation of a c-Myc/Max/DNA complex, or a pharmaceutically acceptable salt thereof.

Abstract: A semiconductor device includes a first word line configured to perform a writing operation or a programing operation, a second word line configured to perform a read operation, a first switching device including a first gate electrode and a first node, a second switching device comprising a second gate electrode and a second node, an electrical fuse (e-fuse) disposed between the first node and the second node, and a diode coupled to the first node and the first word line, wherein the first gate electrode and the second gate electrode are coupled to the second word line.

Abstract: The present invention relates to a pharmaceutical composition for the prophylaxis or treatment of cancer comprising a novel azolopyrimidine heterocyclic compound as an active ingredient, and the pharmaceutical composition for the prophylaxis or treatment of cancer of the present invention can be used as a small molecular immunotherapy anticancer agent which modulates an adenosine pathway by comprising the azolopyrimidine heterocyclic compound.

Abstract: The present invention relates to a combination of biomarkers for diagnosing age-related macular degeneration which is composed of two or more blood biomarkers specific for the diagnosis of age-related macular degeneration with increased diagnostic performance. In addition, the present invention relates to a composition for diagnosing age-related macular degeneration, a diagnostic kit and a method for providing information necessary for the diagnosis of age-related macular degeneration, using the combination of biomarkers. The combination of biomarkers for diagnosing age-related macular degeneration according to the present invention was confirmed to exhibit excellent sensitivity and diagnostic performance compared to other biomarker combinations, and it was also confirmed to exhibit high diagnostic capacity in two stages of early and late age-related macular degeneration when the protein quantitative values of the combination of biomarkers and the basic clinical information were combined and analyzed.

Abstract: The present invention relates to a combination of biomarkers for diagnosing diabetic retinopathy and a use thereof, and more specifically to a combination of biomarkers for diagnosing diabetic retinopathy which is composed of two or more blood biomarkers specific for the diagnosis of diabetic retinopathy with increased diagnostic performance. In addition, the present invention relates to a composition for diagnosing diabetic retinopathy, a diagnostic kit and a method for providing information necessary for the diagnosis of diabetic retinopathy, using the combination of biomarkers.

Abstract: A semiconductor device includes a first word line configured to perform a writing operation or a programing operation, a second word line configured to perform a read operation, a first switching device including a first gate electrode and a first node, a second switching device comprising a second gate electrode and a second node, an electrical fuse (e-fuse) disposed between the first node and the second node, and a diode coupled to the first node and the first word line, wherein the first gate electrode and the second gate electrode are coupled to the second word line.

Abstract: The present invention relates to a compound which inhibits the binding of Yes associated protein (YAP) and transcriptional enhancer associate domain (TEAD), a prodrug of same, a hydrate of same, a solvate of same or a pharmaceutically acceptable salt of same, and a composition comprising same as an active ingredient, the compound according to the present invention being able to be applied as an inhibitor which can directly inhibit YAP-TEAD binding in the Hippo pathway which plays a crucial role in the occurrence of cancer.

Abstract: Provided is a method for treating or preventing cancer, containing, as an active ingredient, a compound having a specific chemical structure and an activity of inhibiting the formation of a c-Myc/Max/DNA complex, or a pharmaceutically acceptable salt thereof.

Abstract: An eFuse cell array includes a first unit cell and a second unit cell, each including a PN diode, a cell read transistor, and a fuse element. A first placement order of the PN diode, the cell read transistor, and the fuse element in the first unit cell is reversed with respect to a second placement order of the PN diode, the cell read transistor, and the fuse element in the second unit cell.

Abstract: Proposed are a laminating apparatus and a method for manufacturing a vehicle seat. The laminating apparatus includes a first lamination part (100); a second lamination part (200); and a drying part (300), wherein the first lamination part (100) includes: a polyurethane foam feeding roll (110); a first bonding part (120); a fabric feeding roll (130) mounted on a side of the first lamination part (100); and a first pressing part (140), the second lamination part (200) includes: a second application part (210); a backing cloth feeding roll (220); and a second pressing part (230), and the drying part (300) includes: a feed part (310); and a chamber part (320).

Abstract: A semiconductor device includes a first word line configured to perform a writing operation or a programing operation, a second word line configured to perform a read operation, a first switching device including a first gate electrode and a first node, a second switching device comprising a second gate electrode and a second node, an electrical fuse (e-fuse) disposed between the first node and the second node, and a diode coupled to the first node and the first word line, wherein the first gate electrode and the second gate electrode are coupled to the second word line.

Abstract: Example embodiments relate to a stacking structure having a material layer formed on a graphene layer, and a method of forming the material layer on the graphene layer. In the stacking structure, when the material layer is formed on the graphene layer by using an ALD method, an intermediate layer as a seed layer may be formed on the graphene layer by using a linear type precursor.

Abstract: A semiconductor device includes a first word line configured to perform a writing operation or a programing operation, a second word line configured to perform a read operation, a first switching device including a first gate electrode and a first node, a second switching device comprising a second gate electrode and a second node, an electrical fuse (e-fuse) disposed between the first node and the second node, and a diode coupled to the first node and the first word line, wherein the first gate electrode and the second gate electrode are coupled to the second word line.

Abstract: Disclosed in an embodiment are a semiconductor device and a semiconductor device package including the same, the semiconductor device comprising: a semiconductor structure including a first light emitting unit and a second light emitting unit; a first electrode for electrically connecting a first conductive type semiconductor layer of the first light emitting unit with a first conductive type semiconductor layer of the second light emitting unit; and a second electrode for electrically connecting a second conductive type semiconductor layer of the first light emitting unit with a second conductive type semiconductor layer of the second light emitting unit, wherein: the first electrode includes a first pad arranged on the first light emitting unit, a first branch electrode arranged on the first light emitting unit, and a first extension electrode arranged on the second light emitting unit; the second electrode includes a second pad arranged on the second light emitting unit, a second branch electrode arranged

Abstract: An eFuse cell array includes a first unit cell and a second unit cell, each including a PN diode, a cell read transistor, and a fuse element. A first placement order of the PN diode, the cell read transistor, and the fuse element in the first unit cell is reversed with respect to a second placement order of the PN diode, the cell read transistor, and the fuse element in the second unit cell.

Abstract: A semiconductor device includes a first word line configured to perform a writing operation or a programing operation, a second word line configured to perform a read operation, a first switching device including a first gate electrode and a first node, a second switching device comprising a second gate electrode and a second node, an electrical fuse (e-fuse) disposed between the first node and the second node, and a diode coupled to the first node and the first word line, wherein the first gate electrode and the second gate electrode are coupled to the second word line.